Coretec Group Inc (CRTG)

[Testpilot]

How This Impacts Your Core Narrative (CRTG + DKME + Core Optics)

You’ve been building around this structure:

* The Coretec Group (parent / umbrella)
* Core Optics (˜ ~$16M assumed revenue)
* DKME Co., Ltd. (potential high-revenue piece)

👉 This KRX update is a critical gatekeeper event for that entire story.

?

🔗 Scenario Modeling (What Happens Next)

🟢 SCENARIO 1 — DKME PASSES REVIEW (Bull Case)

What it means:

* KRX accepts the improvement plan
* DKME proves:
* It is a legitimate, functioning company
* Financials are credible enough for continued listing

Impact on your thesis:

* ✔️ Validates DKME as a real revenue engine
* ✔️ Strengthens probability of:
* CRTG consolidation narrative
* Subsidiary / ownership linkage credibility

Valuation Implication:

If:

* Core Optics ˜ $16M
* DKME (even conservatively) ˜ $50M–$100M+

👉 Combined narrative:

* $66M–$116M+ revenue story

Even at 1x–2x revenue multiple (low for tech/energy):

* $66M ? $132M valuation range (low case)
* $116M ? $232M valuation range

👉 Compared to microcap valuation:

* That’s massive upside IF structure is real

?

🔴 SCENARIO 2 — DKME FAILS (Bear Case)

What it means:

* KRX rejects improvement plan
* Possible:
* Delisting
* Severe trading restrictions
* Financial credibility collapse

Impact:

* ❌ DKME revenue assumptions = unreliable
* ❌ CRTG “multi-entity growth story” weakens significantly

Valuation Impact:

* CRTG becomes:
* Primarily a single small entity story
* Likely reverts to:
* Speculative / shell-like valuation range

👉 This is the biggest downside risk to your thesis

?

🟡 SCENARIO 3 — EXTENDED DELAY (Most Likely Near-Term)

What’s happening now 👇

* KRX says: “We need more time”

Translation:

* Something is:
* Not clearly fraudulent ❌
* Not clearly solid ✔️

👉 It’s in the gray zone

Impact:

* Narrative remains alive—but unproven
* Market typically:
* Discounts heavily during uncertainty

?

🔍 Key Insight (This Is Important)

This delay tells us:

DKME likely submitted something substantive—but not fully convincing yet

That’s actually meaningful.

Because:

* If there were nothing there ? fast rejection
* If it were fully clean ? fast approval

👉 You’re in the “prove it” phase

?

⚠️ What You Should Watch VERY Closely

1. Final Committee Decision

This is the binary trigger event

?

2. Financial Transparency Signals

Look for:

* Audited financials
* Revenue breakdown
* Cash flow clarity

?

3. Ownership / Structure Clarity

This directly affects your thesis:

* Does DKME clearly link to CRTG?
* Is there:
* Equity ownership?
* Control?
* Board overlap?

👉 If not confirmed ? valuation story weakens

?

🧠 Strategic Investor Take (Blunt Version)

Right now:

* You have a high-upside but unverified structure play

?

The reality:

* This is NOT yet an “investment-grade thesis”
* It is a:
Speculative asymmetric opportunity

?

The pivot point:

👉 DKME’s approval outcome

That’s the linchpin

?

📊 Bottom Line

* This delay = alive, but under scrutiny
* Your upside case still exists
* But it is entirely dependent on validation